-

Eurofins Scientific announces the acquisition of Labormar, further expanding its presence in Latin America and its Food and Feed, Environmental, Cosmetic and Pharmacological testing offering in Colombia

BARRANQUILLA, Colombia--(BUSINESS WIRE)--The Eurofins network of companies, a world leader in food, environment, pharmaceutical and cosmetic product testing, announces the completion of the acquisition of Labormar. The acquisition will further strengthen the Eurofins network’s global food and feed, cosmetic and pharmacological, and environmental testing offering and its presence in Latin America.

Known as Eurofins Labormar going forward, the laboratory represents the second Eurofins laboratory in Colombia. Headquartered in Barranquilla, Labormar is nationally recognised as a reference laboratory in the provision of high-quality food and feed, cosmetics and pharmacological safety and quality control testing, and environmental management and personalised consulting solutions.

Labormar’s 90 employees based at 10 locations, comprising a laboratory and 9 logistics and sampling hubs providing national coverage, support governmental agencies, private companies and industry bodies and organisations with the highest quality standards and turnaround time.

The origins of the Eurofins network’s presence in Latin America dates back to 2001, when Eurofins Genescan first established a presence in Brazil, setting up an office in São Paulo/SP, shortly followed by the opening of a laboratory. Since then, the Eurofins network of companies has continued to expand in Latin America, with more than 15 laboratories across 5 LATAM countries now operating across food, environmental, pharmaceutical, agroscience and clinical diagnostics testing segments, as well as providing specialised consultancy and audit services. To learn more, please visit: www.eurofins.com.br

About Eurofins – the global leader in bio-analysis

Eurofins is Testing for Life. With ca. 62,000 staff across a network of more than 900 laboratories in over 1,000 companies in 62 countries, Eurofins offers a portfolio of over 200,000 analytical methods.

Eurofins Scientific S.E. shares are listed on Euronext Paris Stock Exchange.

About Eurofins Labormar:

Eurofins Labormar comprises a laboratory headquartered on the Barranquilla coast and 9 logistic and sampling hubs positioned to provide national coverage. Eurofins Labormar is accredited to all local and market requirements, and through its analytical and testing support to clients in a myriad of sector, is recognised as a national leader in the provision of high-quality food safety and environmental control solutions.

Contacts

For further information: edbr-marketing@eurofinslatam.com

Eurofins

BOURSE:ERF

Release Versions

Contacts

For further information: edbr-marketing@eurofinslatam.com

More News From Eurofins

Eurofins Announces the Successful Closing of Its Acquisition of SYNLAB’s Clinical Diagnostics Operations in Spain

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific (EUFI.PA), a global scientific leader in bioanalytical testing, with a rapidly developing presence in highly specialised and molecular clinical diagnostics testing and in-vitro diagnostics products, announces the successful closing of the acquisition of SYNLAB’s clinical diagnostics operations in Spain and the transfer of operations to Eurofins, which took place on 31 March 2025. SYNLAB’s clinical diagnostics operations in Spain...

Eurofins: Purchases of Own Shares from March 24th to March 28th 2025

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): Name of the Issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS 529900JEHFM47DYY3S57 24/03/2025 FR0014000MR3 112,452 51.0468 XPAR EUROFINS 529900JEHFM47DYY3S57 24/03/2025 FR0014000MR3 33,548 50.9670 CEUX EUROFINS 529900JEHFM47DYY3S57 24/03/2025 FR0014000MR3 2,000...

Eurofins Successfully Prices New Hybrid Bonds of €400m

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): Eurofins Scientific (EUFI.PA, rated Baa3 by Moody’s and BBB- by Fitch), a global leader in bioanalytical testing, announces that it has successfully raised €400m in its latest Euro hybrid bond public issuance. The transaction was well received and more than 3x times over-subscribed. This new series of bonds has no specified maturity date and is accounted for as 100% equity according to international financial reporting standard...
Back to Newsroom